Friend or Foe? The Roles of Antioxidants in Acute Lung Injury

被引:20
|
作者
Liu, Yang [1 ]
Zhou, Shujun [2 ]
Xiang, Du [2 ]
Ju, Lingao [3 ,4 ]
Shen, Dexin [1 ]
Wang, Xinghuan [1 ]
Wang, Yanfeng [2 ]
机构
[1] Wuhan Univ, Dept Urol, Zhongnan Hosp, Wuhan 430071, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Inst Hepatobiliary Dis, Transplant Ctr, Wuhan 430071, Peoples R China
[3] Wuhan Univ, Dept Biol Repositories, Zhongnan Hosp, Wuhan 430071, Peoples R China
[4] Human Genet Resource Preservat Ctr Hubei Prov, Wuhan 430071, Peoples R China
关键词
acute lung injury; reactive oxygen species; oxygen radical; antioxidants; ACUTE RESPIRATORY-DISTRESS; HIGH-DOSE AMBROXOL; N-ACETYLCYSTEINE; VITAMIN-E; OXIDATIVE STRESS; FREE HEMOGLOBIN; MURINE MODEL; RAT LUNG; SUPPLEMENTATION; INFLAMMATION;
D O I
10.3390/antiox10121956
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute lung injury (ALI) is an acute hypoxic respiratory insufficiency caused by various intra- and extra-pulmonary injury factors. The oxidative stress caused by excessive reactive oxygen species (ROS) produced in the lungs plays an important role in the pathogenesis of ALI. ROS is a "double-edged sword", which is widely involved in signal transduction and the life process of cells at a physiological concentration. However, excessive ROS can cause mitochondrial oxidative stress, leading to the occurrence of various diseases. It is well-known that antioxidants can alleviate ALI by scavenging ROS. Nevertheless, more and more studies found that antioxidants have no significant effect on severe organ injury, and may even aggravate organ injury and reduce the survival rate of patients. Our study introduces the application of antioxidants in ALI, and explore the mechanisms of antioxidants failure in various diseases including it.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] The lung's friend, the gut's foe
    Hildebrandt, Gerhard
    BLOOD, 2007, 110 (03) : 792 - 793
  • [32] Extrapericardial fat: friend or foe in lung transplantation
    Chow, Bobby Hiu Nam
    Dimarakis, Ioannis
    BMJ CASE REPORTS, 2022, 15 (11)
  • [33] FUROSEMIDE DURING ACUTE KIDNEY INJURY AND FAILURE IN CRITICALLY ILL CHILDREN: FRIEND OR FOE?
    Reiter, Pamela D.
    Berg, Allyson
    Dobyns, Emily L.
    CRITICAL CARE MEDICINE, 2012, 40 (12) : U250 - U251
  • [34] Opioids in Acute Coronary Syndromes: Friend or Foe?
    Maryna V. Basalay
    Derek M. Yellon
    Sean M. Davidson
    Cardiovascular Drugs and Therapy, 2022, 36 : 1001 - 1003
  • [35] Interventional Radiology in Acute Pancreatitis: Friend or Foe?
    Khorsandi, Maziar
    Beatson, Kevin
    Dougherty, Scott
    Zealley, Ian
    Kulli, Christoph
    JOURNAL OF THE PANCREAS, 2012, 13 (01): : 91 - 93
  • [36] Gasotransmitters in Acute Necrotizing Pancreatitis: Friend or Foe?
    Chooklin, S.
    Pidhirnyy, Y.
    Chuklin, S.
    Usach, O.
    PANCREAS, 2015, 44 (08) : 1366 - 1366
  • [37] Opioids in Acute Coronary Syndromes: Friend or Foe?
    Basalay, Maryna V.
    Yellon, Derek M.
    Davidson, Sean M.
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (05) : 1001 - 1003
  • [38] Friend or Foe? Essential Roles of Osteoclast in Maintaining Skeletal Health
    Wang, Haixing
    Yang, Guangpu
    Xiao, Yinbo
    Luo, Guotian
    Li, Gang
    Li, Ziqing
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [39] FOLATE: FRIEND OR FOE? AN INVESTIGATION INTO THE OPPOSING ROLES OF FOLATE IN GLIOMA
    Rudd, Michelle Claire
    Lea, Robert
    Alder, Jane
    NEURO-ONCOLOGY, 2018, 20 : 17 - 17
  • [40] The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?
    Glorieux, Christophe
    Enriquez, Cinthya
    Gonzalez, Constanza
    Aguirre-Martinez, Gabriela
    Calderon, Pedro Buc
    ANTIOXIDANTS, 2024, 13 (01)